Rubric Capital Management LP Actinium Pharmaceuticals, Inc. Transaction History

Rubric Capital Management LP

  • $6.05 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$7.62 - $9.79 $2.25 Million - $2.88 Million
-294,683 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$7.8 - $12.64 $1.85 Million - $3 Million
237,165 Added 412.33%
294,683 $2.3 Million
Q3 2020

Nov 13, 2020
BUY
$7.26 - $18.0 $417,580 - $1.04 Million
57,518 New
57,518 $557,000

Others Institutions Holding ATNM

# of Institutions
70
Shares Held
7.94M
Call Options Held
59.6K
Put Options Held
4.8K
View Full List

About Actinium Pharmaceuticals, Inc.

ATNM Quotes by TradingView
  • Ticker ATNM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,184,700
  • Market Cap $39M
  • Description
  • Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...
More about ATNM
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email